These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 17360873

  • 1. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
    Kitchener S, Nasveld P, Edstein MD.
    Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.
    Walsh DS, Looareesuwan S, Wilairatana P, Heppner DG, Tang DB, Brewer TG, Chokejindachai W, Viriyavejakul P, Kyle DE, Milhous WK, Schuster BG, Horton J, Braitman DJ, Brueckner RP.
    J Infect Dis; 1999 Oct; 180(4):1282-7. PubMed ID: 10479159
    [Abstract] [Full Text] [Related]

  • 4. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Möhrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L.
    Lancet; 2014 Mar 22; 383(9922):1049-58. PubMed ID: 24360369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
    Walsh DS, Eamsila C, Sasiprapha T, Sangkharomya S, Khaewsathien P, Supakalin P, Tang DB, Jarasrumgsichol P, Cherdchu C, Edstein MD, Rieckmann KH, Brewer TG.
    J Infect Dis; 2004 Oct 15; 190(8):1456-63. PubMed ID: 15378438
    [Abstract] [Full Text] [Related]

  • 7. Treatment of acute vivax malaria with tafenoquine.
    Nasveld P, Kitchener S.
    Trans R Soc Trop Med Hyg; 2005 Jan 15; 99(1):2-5. PubMed ID: 15550254
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
    Sharma R, Sharma H, Jones S, Borghini-Fuhrer I, Domingo GJ, Gibson RA, Rolfe K, Tan L, Fiţa IG, Chen C, Bird P, Pingle A, Duparc S.
    Malar J; 2024 May 13; 23(1):145. PubMed ID: 38741094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS, Ghosh SK.
    J Parasitol; 2002 Oct 13; 88(5):1042-4. PubMed ID: 12435158
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
    Hamedi Y, Safa O, Zare S, Tan-ariya P, Kojima S, Looareesuwan S.
    Southeast Asian J Trop Med Public Health; 2004 Sep 13; 35(3):570-4. PubMed ID: 15689068
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
    Fukuda MM, Krudsood S, Mohamed K, Green JA, Warrasak S, Noedl H, Euswas A, Ittiverakul M, Buathong N, Sriwichai S, Miller RS, Ohrt C.
    PLoS One; 2017 Sep 13; 12(11):e0187376. PubMed ID: 29121061
    [Abstract] [Full Text] [Related]

  • 20. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
    Buchachart K, Krudsood S, Singhasivanon P, Treeprasertsuk S, Phophak N, Srivilairit S, Chalermrut K, Rattanapong Y, Supeeranuntha L, Wilairatana P, Brittenham G, Looareesuwan S.
    Southeast Asian J Trop Med Public Health; 2001 Dec 13; 32(4):720-6. PubMed ID: 12041544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.